Tag: Antibody-drug conjugates

Tarveda Therapeutics Inc.

Loncastuximab tesirine

Click the tags to see associated articles and topics

View Article Details

How Good Does Seattle Genetics (NASDAQ:SGEN) Look Now? Merrill Lynch Has Just Upgraded ...

Added to Collection on: 2018-01-13 05:22:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Seattle Genetics, Inc. (SGEN) Analysts See $-0.41 EPS

Added to Collection on: 2018-04-25 05:22:30

Tags for this article:

Clinical medicine

NASDAQ

Biotechnology

Drugs

Diffuse large B-cell lymphoma

S&P 500 INDEX - CBOE

Denintuzumab mafodotin

Click the tags to see associated articles and topics

View Article Details

What Next for Seattle Genetics Inc (NASDAQ:SGEN) Stock After Decrease in Shorted Shares?

Added to Collection on: 2018-06-08 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Seattle Genetics (NASDAQ:SGEN): HC Wainwright Reiterates “Buy” Rating Today, Has a Target of ...

Added to Collection on: 2018-07-26 20:29:49

Tags for this article:

SGN-CD19A

Click the tags to see associated articles and topics

View Article Details

$-0.28 EPS Expected for Seattle Genetics, Inc. (SGEN); Ativo Capital Management Has Decreased ...

Added to Collection on: 2019-04-08 01:20:30

Tags for this article:

Ativo Capital Management LLC

Drugs

Team SoloMid

Glembatumumab vedotin

Abu Dhabi SE Industrial Index

S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details

Global Cancer Antibodies Drug Conjugate Antibody Market To Reach USD 13 Billion By 2026

Added to Collection on: 2020-10-22 21:52:30

Tags for this article:

Antibody

Antibody-drug conjugate

Bispecific monoclonal antibody

Biotechnology